Geode Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.97B Buy
28,635,233
+675,824
+2% +$46.4M 0.14% 122
2025
Q1
$1.89B Buy
27,959,409
+907,869
+3% +$61.3M 0.15% 119
2024
Q4
$1.21B Buy
27,051,540
+689,867
+3% +$30.9M 0.09% 181
2024
Q3
$1.65B Buy
26,361,673
+461,569
+2% +$28.9M 0.13% 127
2024
Q2
$1.53B Buy
25,900,104
+518,029
+2% +$30.5M 0.13% 123
2024
Q1
$2.02B Buy
25,382,075
+871,918
+4% +$69.4M 0.19% 97
2023
Q4
$1.93B Buy
24,510,157
+580,027
+2% +$45.7M 0.2% 93
2023
Q3
$1.67B Buy
23,930,130
+604,843
+3% +$42.1M 0.2% 92
2023
Q2
$1.61B Buy
23,325,287
+363,384
+2% +$25M 0.19% 96
2023
Q1
$1.7B Sell
22,961,903
-369,195
-2% -$27.4M 0.22% 86
2022
Q4
$2.17B Sell
23,331,098
-43,323
-0.2% -$4.03M 0.3% 61
2022
Q3
$2.23B Buy
23,374,421
+186,288
+0.8% +$17.7M 0.34% 49
2022
Q2
$2.14B Buy
23,188,133
+761,218
+3% +$70.4M 0.31% 58
2022
Q1
$2.26B Buy
22,426,915
+327,715
+1% +$33.1M 0.28% 63
2021
Q4
$2.27B Buy
22,099,200
+408,181
+2% +$42M 0.27% 67
2021
Q3
$1.84B Buy
21,691,019
+541,650
+3% +$45.8M 0.25% 75
2021
Q2
$1.76B Buy
21,149,369
+678,557
+3% +$56.5M 0.24% 76
2021
Q1
$1.54B Buy
20,470,812
+441,924
+2% +$33.2M 0.23% 76
2020
Q4
$1.36B Buy
20,028,888
+275,609
+1% +$18.8M 0.23% 78
2020
Q3
$1.15B Buy
19,753,279
+107,954
+0.5% +$6.29M 0.23% 82
2020
Q2
$1.27B Buy
19,645,325
+399,947
+2% +$25.9M 0.27% 67
2020
Q1
$1.14B Buy
19,245,378
+577,235
+3% +$34.2M 0.3% 62
2019
Q4
$1.38B Buy
18,668,143
+337,843
+2% +$25M 0.29% 65
2019
Q3
$1.15B Buy
18,330,300
+365,253
+2% +$23M 0.27% 69
2019
Q2
$977M Buy
17,965,047
+397,185
+2% +$21.6M 0.24% 78
2019
Q1
$946M Buy
17,567,862
+1,105,570
+7% +$59.5M 0.25% 81
2018
Q4
$1.08B Buy
16,462,292
+4,376,604
+36% +$286M 0.33% 58
2018
Q3
$950M Sell
12,085,688
-121,462
-1% -$9.54M 0.27% 67
2018
Q2
$784M Buy
12,207,150
+758,150
+7% +$48.7M 0.24% 72
2018
Q1
$711M Buy
11,449,000
+580,669
+5% +$36M 0.23% 83
2017
Q4
$786M Buy
10,868,331
+235,357
+2% +$17M 0.27% 70
2017
Q3
$863M Buy
10,632,974
+246,659
+2% +$20M 0.32% 58
2017
Q2
$834M Buy
10,386,315
+546,364
+6% +$43.9M 0.33% 57
2017
Q1
$771M Buy
9,839,951
+414,867
+4% +$32.5M 0.32% 58
2016
Q4
$743M Buy
9,425,084
+648,919
+7% +$51.1M 0.35% 53
2016
Q3
$780M Buy
8,776,165
+192,933
+2% +$17.1M 0.39% 45
2016
Q2
$820M Sell
8,583,232
-333,808
-4% -$31.9M 0.45% 42
2016
Q1
$923K Buy
8,917,040
+77,690
+0.9% +$8.04K 0.49% 39
2015
Q4
$862M Sell
8,839,350
-8,309
-0.1% -$811K 0.49% 40
2015
Q3
$852M Sell
8,847,659
-106,587
-1% -$10.3M 0.52% 36
2015
Q2
$937M Sell
8,954,246
-297,318
-3% -$31.1M 0.54% 33
2015
Q1
$953M Buy
9,251,564
+293,583
+3% +$30.3M 0.55% 33
2014
Q4
$862M Buy
8,957,981
+208,821
+2% +$20.1M 0.51% 36
2014
Q3
$695M Sell
8,749,160
-145,076
-2% -$11.5M 0.45% 38
2014
Q2
$670M Sell
8,894,236
-222,285
-2% -$16.7M 0.43% 39
2014
Q1
$682M Buy
9,116,521
+73,537
+0.8% +$5.5M 0.46% 38
2013
Q4
$647M Buy
9,042,984
+223,177
+3% +$16M 0.45% 41
2013
Q3
$500M Buy
8,819,807
+316,530
+4% +$18M 0.4% 47
2013
Q2
$486M Buy
+8,503,277
New +$486M 0.43% 43